Literature DB >> 24578129

Mechanism of salt-sensitive hypertension: focus on adrenal and sympathetic nervous systems.

Toshiro Fujita1.   

Abstract

A central role for the kidney among the systems contributing to BP regulation and the development of hypertension has been proposed. Both the aldosterone/mineralocorticoid receptor pathway and the renal sympathetic nervous system have important roles in the regulation of renal excretory function and BP control, but the mechanisms underlying these processes have remained unclear. However, recent studies revealed the activation of two pathways in salt-sensitive hypertension. Notably, Rac1, a member of the Rho-family of small GTP binding proteins, was identified as a novel ligand-independent modulator of mineralocorticoid receptor activity. Furthermore, these studies point to crucial roles for the Rac1-mineralocorticoid receptor-NCC/ENaC and the renal β-adrenergic stimulant-glucocorticoid receptor-WNK4-NCC pathways in certain rodent models of salt-sensitive hypertension. The nuclear mineralocorticoid and glucocorticoid receptors may contribute to impaired renal excretory function and the resulting salt-sensitive hypertension by increasing sodium reabsorption at different tubular segments. This review provides an in-depth discussion of the evidence supporting these conclusions and considers the significance with regard to treating salt-sensitive hypertension and salt-induced cardiorenal injury.
Copyright © 2014 by the American Society of Nephrology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24578129      PMCID: PMC4033384          DOI: 10.1681/ASN.2013121258

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  87 in total

1.  Decreased ENaC expression compensates the increased NCC activity following inactivation of the kidney-specific isoform of WNK1 and prevents hypertension.

Authors:  Juliette Hadchouel; Christelle Soukaseum; Cara Büsst; Xiao-ou Zhou; Véronique Baudrie; Tany Zürrer; Michelle Cambillau; Jean-Luc Elghozi; Richard P Lifton; Johannes Loffing; Xavier Jeunemaitre
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

2.  Dietary salt modulates the sodium chloride cotransporter expression likely through an aldosterone-mediated WNK4-ERK1/2 signaling pathway.

Authors:  Lingyun Lai; Xiuyan Feng; Defeng Liu; Jing Chen; Yiqian Zhang; Bowen Niu; Yong Gu; Hui Cai
Journal:  Pflugers Arch       Date:  2011-12-27       Impact factor: 3.657

3.  Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule.

Authors:  Maria D Lalioti; Junhui Zhang; Heather M Volkman; Kristopher T Kahle; Kristin E Hoffmann; Hakan R Toka; Carol Nelson-Williams; David H Ellison; Richard Flavell; Carmen J Booth; Yin Lu; David S Geller; Richard P Lifton
Journal:  Nat Genet       Date:  2006-09-10       Impact factor: 38.330

Review 4.  Heterogeneous responses to changes in dietary salt intake: the salt-sensitivity paradigm.

Authors:  F C Luft; M H Weinberger
Journal:  Am J Clin Nutr       Date:  1997-02       Impact factor: 7.045

5.  Enhanced phosphorylation of Na(+)-Cl- co-transporter in experimental metabolic syndrome: role of insulin.

Authors:  Radko Komers; Shaunessy Rogers; Terry T Oyama; Bei Xu; Chao-Ling Yang; James McCormick; David H Ellison
Journal:  Clin Sci (Lond)       Date:  2012-12       Impact factor: 6.124

6.  Localization of thiazide-sensitive Na(+)-Cl(-) cotransport and associated gene products in mouse DCT.

Authors:  V Câmpean; J Kricke; D Ellison; F C Luft; S Bachmann
Journal:  Am J Physiol Renal Physiol       Date:  2001-12

7.  Reversal of genetic salt-sensitive hypertension by targeted sympathetic ablation.

Authors:  Jason D Foss; Gregory D Fink; John W Osborn
Journal:  Hypertension       Date:  2013-02-04       Impact factor: 10.190

8.  Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in obesity-induced hypertension.

Authors:  Ai Nagae; Megumi Fujita; Hiroo Kawarazaki; Hiromitsu Matsui; Katsuyuki Ando; Toshiro Fujita
Journal:  Circulation       Date:  2009-02-09       Impact factor: 29.690

9.  Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury.

Authors:  James M Luther; Pengcheng Luo; Zuofei Wang; Samuel E Cohen; Hyung-Suk Kim; Agnes B Fogo; Nancy J Brown
Journal:  Kidney Int       Date:  2012-05-23       Impact factor: 10.612

10.  Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors.

Authors:  Amy McCurley; Paulo W Pires; Shawn B Bender; Mark Aronovitz; Michelle J Zhao; Daniel Metzger; Pierre Chambon; Michael A Hill; Anne M Dorrance; Michael E Mendelsohn; Iris Z Jaffe
Journal:  Nat Med       Date:  2012-09       Impact factor: 53.440

View more
  42 in total

1.  Lack of Suppression of Aldosterone Production Leads to Salt-Sensitive Hypertension in Female but Not Male Balb/C Mice.

Authors:  Jessica L Faulkner; Daisy Harwood; Lily Bender; Lenee Shrestha; Michael W Brands; M Jane Morwitzer; Simone Kennard; Galina Antonova; Eric J Belin de Chantemèle
Journal:  Hypertension       Date:  2018-12       Impact factor: 10.190

Review 2.  Charting a TRP to Novel Therapeutic Destinations for Kidney Diseases.

Authors:  Juan Lorenzo Pablo; Anna Greka
Journal:  Trends Pharmacol Sci       Date:  2019-11-05       Impact factor: 14.819

3.  (Pro)renin receptor knockdown in the paraventricular nucleus of the hypothalamus attenuates hypertension development and AT1 receptor-mediated calcium events.

Authors:  Lucas A C Souza; Caleb J Worker; Wencheng Li; Fatima Trebak; Trevor Watkins; Ariana Julia B Gayban; Evan Yamasaki; Silvana G Cooper; Bernard T Drumm; Yumei Feng
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-03-29       Impact factor: 4.733

4.  Perinatal iron deficiency and a high salt diet cause long-term kidney mitochondrial dysfunction and oxidative stress.

Authors:  Andrew G Woodman; Richard Mah; Danae L Keddie; Ronan M N Noble; Claudia D Holody; Sareh Panahi; Ferrante S Gragasin; Helene Lemieux; Stephane L Bourque
Journal:  Cardiovasc Res       Date:  2020-01-01       Impact factor: 10.787

Review 5.  Drug therapy of apparent treatment-resistant hypertension: focus on mineralocorticoid receptor antagonists.

Authors:  Daniel Glicklich; William H Frishman
Journal:  Drugs       Date:  2015-04       Impact factor: 9.546

Review 6.  Sensory signals mediating high blood pressure via sympathetic activation: role of adipose afferent reflex.

Authors:  Carolina Dalmasso; Jacqueline R Leachman; Jeffrey L Osborn; Analia S Loria
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-12-23       Impact factor: 3.619

Review 7.  Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited.

Authors:  Alexandre A da Silva; Jussara M do Carmo; Xuan Li; Zhen Wang; Alan J Mouton; John E Hall
Journal:  Can J Cardiol       Date:  2020-02-12       Impact factor: 5.223

8.  Alpha2B-Adrenergic Receptor Overexpression in the Brain Potentiate Air Pollution-induced Behavior and Blood Pressure Changes.

Authors:  Xiaoquan Rao; Laureano D Asico; Panos Zanos; Ganapati H Mahabeleshwar; Roopesh Singh Gangwar; Chang Xia; Lihua Duan; Yasmine-Marie Cisse; Palanivel Rengasamy; Pedro A Jose; Todd D Gould; Randy Nelson; Shyam Biswal; Lung-Chi Chen; Jixin Zhong; Sanjay Rajagopalan
Journal:  Toxicol Sci       Date:  2019-05-01       Impact factor: 4.849

Review 9.  Gut microbiota in hypertension.

Authors:  Pedro A Jose; Dominic Raj
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-09       Impact factor: 2.894

Review 10.  Kidney and epigenetic mechanisms of salt-sensitive hypertension.

Authors:  Wakako Kawarazaki; Toshiro Fujita
Journal:  Nat Rev Nephrol       Date:  2021-02-24       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.